The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

NCT01767909 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Amnestic Mild Cognitive Impairment
Alzheimer's Disease

Interventions

DRUG: Insulin (Humulin® R U-100)
DRUG: Placebo

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]
[object Object]